These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7259535)

  • 1. Antiatherogenic effect of pyridinolcarbamate (prodectin). Experimental study.
    Orbetzova V; Jurukova Z; Orbetzova M
    Artery; 1980; 8(6):560-9. PubMed ID: 7259535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of clofibrate (Miscleron) and pyridinol carbamate (Prodectin) on immunologic factors in experimental arteriosclerosis].
    Szondy E; Horváth M; Füst G; Fehér J; Link E; Gerö S
    Orv Hetil; 1979 Jun; 120(23):1391-2. PubMed ID: 492681
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical and laboratory examinations with Prodectin.
    Bédi J; Kosztovics A; Pálos LA
    Ther Hung; 1976; 24(3):91-7. PubMed ID: 1013926
    [No Abstract]   [Full Text] [Related]  

  • 4. [The comparative characteristics of the antiatherogenic effect of xymedon and parmidine].
    Kamburg RA; Ibragimov OB; Kondrat'eva MB; Valeeva IKh; Shamsutdinov NSh
    Biull Eksp Biol Med; 1993 Aug; 116(8):205-8. PubMed ID: 8274706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of ethirazol and parmidine ofn the development of experimental atherosclerosis in rabbits].
    Ryzhenkov VE; Tararak EM; Khechinashvili GG; Mosina IV
    Biull Eksp Biol Med; 1976 May; 81(5):558-9. PubMed ID: 947379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of pyridinol carbamate on long-term lathyrism and experimental atheroma in the rat. Histological and biochemical study].
    Bouissou H; de Graeve J; Julian M; Pieraggi MT; Thiers JC
    Paroi Arterielle; 1980; 6(1):3-15. PubMed ID: 7422355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyridinolcarbamate and experimental atherosclerosis. Correlation of hypocholesterolemic and antiatherogenic effects.
    Albert EN; Kassira WN; Muesing R; Vahouny GV
    Atherosclerosis; 1978 Oct; 31(2):205-15. PubMed ID: 728238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of piridinol carbamate on hypercholesteremia and aortal damage produced by 5 days' application of Altman's diet to the rat.
    Iwanowska J; Starzyński S; Kalinowska A
    Pol J Pharmacol Pharm; 1980; 32(3):333-41. PubMed ID: 6974352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antiatherogenic properties of olive oil and its constituent lipid classes in hyperlipidemic rabbits.
    Karantonis HC; Antonopoulou S; Perrea DN; Sokolis DP; Theocharis SE; Kavantzas N; Iliopoulos DG; Demopoulos CA
    Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):174-85. PubMed ID: 16580585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-atherosclerotic and plasma lipid lowering effects of the novel calcium blocker with alpha 1-adrenoceptor antagonistic activity, monatepil, in high cholesterol diet-fed Japanese Macaca fuscata monkeys.
    Miyazaki M; Hosoki K; Okunishi H; Ishii K; Ikeno A; Okazaki Y
    Arzneimittelforschung; 1994 Mar; 44(3):288-97. PubMed ID: 8192692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antiatherogenic L-aspartate and L-glutamate on serum lipoproteins cholesterol and apolipoproteins A-1 and B in rabbits fed with high cholesterol diet.
    Yanni AE; Perrea DN; Yatzidis HA
    Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):161-5. PubMed ID: 15955463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ["Bu-yang huanwu tang" inhibited the pathogentic process of atherosclerosis induced by cholesterol-rich diet in rabbits].
    Liu FY; Wen ZB; Zhou CS; Yang XP; Shang GP; He SL; Li JC
    Hunan Yi Ke Da Xue Xue Bao; 2000 Feb; 25(1):33-5. PubMed ID: 12212241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial suppression by pyridinolcarbamate of growth and necrosis of atherosclerotic lesions in swine subjected to an atherogenic regimen that produces advanced lesions.
    Lee WM; Lee KT; Thomas WA
    Exp Mol Pathol; 1979 Feb; 30(1):85-93. PubMed ID: 421864
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic effect of pyridinolcarbamate on rats kept on a high-fat and cholesterol diet or treated with calciferol.
    Grafnetter D; Shimamoto T; Numano F
    Cor Vasa; 1973; 15(1):58-69. PubMed ID: 4540865
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prodectin treatment of partial hearing loss as a result of atherosclerosis].
    Smirnova NA; Timakov VA; Mikushkin MK
    Vestn Otorinolaringol; 1982; (6):53-6. PubMed ID: 7179649
    [No Abstract]   [Full Text] [Related]  

  • 16. [Aortic expression of monocyte chemotactic protein-1 (MCP-1) gene in rabbits with experimental atherosclerosis].
    Sekalska B
    Ann Acad Med Stetin; 2003; 49():79-90. PubMed ID: 15552841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of complamin and prodectin on microcirculation and lipid metabolism in psoriasis patients].
    Rakhmatov AB; Bilash NV
    Vestn Dermatol Venerol; 1983 Apr; (4):15-8. PubMed ID: 6868813
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of bioflavonoids and lecithin on the course of experimental atherosclerosis in rabbits].
    Białecka M
    Ann Acad Med Stetin; 1997; 43():41-56. PubMed ID: 9471922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of ximedon on cholesterol metabolism and experimental atherosclerosis in rabbits].
    Dautova GS; Kosykh VA; Repin VS; Kamburg RA; Ibragimov OB; Popova LG; Valeeva IKh
    Eksp Klin Farmakol; 1995; 58(1):25-9. PubMed ID: 7787689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of Prodectin (pyridinolcarbamate) treatment of the circulation rate in obliterating arterial diseases of the lower extremities.
    Fényes G; Gótzy G; Fehrentheil L
    Ther Hung; 1975; 23(2):64-66. PubMed ID: 1188705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.